Medically Reviewed Content
Written by Rob Anderson, Health Technology Researcher & Medical Content Specialist. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting any medication.
One of the most common sources of confusion when starting semaglutide is understanding the dosing schedule. Here is the complete guide to doses, escalation, and what to do if things are not going smoothly.
The Standard Wegovy Escalation Schedule
| Week | Dose | Purpose |
|---|---|---|
| 1–4 | 0.25mg/week | Adaptation — not therapeutic for weight loss |
| 5–8 | 0.5mg/week | Initial therapeutic range |
| 9–12 | 1.0mg/week | Increased efficacy |
| 13–16 | 1.7mg/week | Approaching full dose |
| 17+ | 2.4mg/week | Maintenance — maximum approved dose for weight loss |
Compounded Semaglutide Dosing
Compounded semaglutide providers vary in their escalation protocols. Common approaches: standard Wegovy-equivalent schedule; a more gradual “slow escalation” option (0.25mg → 0.5mg → 1mg → 1.5mg → 2mg → 2.4mg over 20–24 weeks) for GI-sensitive patients; or patient-controlled escalation where you stay at each dose until comfortable before advancing. Ask your provider what escalation protocol they recommend and whether they offer flexibility.
Ozempic Doses (Diabetes Indication)
For type 2 diabetes management, the approved Ozempic doses are 0.5mg, 1mg, and 2mg weekly. The escalation is similar: start 0.25mg for 4 weeks, then 0.5mg. After 4+ weeks at 0.5mg, can increase to 1mg if additional glycaemic control is needed, and to 2mg if further improvement is required. The 2mg dose is primarily for diabetes and was added later than the original 0.5/1mg approvals.
What to Do if a Dose Is Not Tolerated
If nausea, vomiting, or other GI effects are intolerable after a dose increase: stay at the previous dose for a further 4 weeks before attempting the increase again. If you missed an injection (more than 5 days late for weekly semaglutide), skip that dose and resume your regular schedule the following week — do not double-dose. If you are severely unwell, contact your prescriber about whether a dose reduction or temporary pause is appropriate.
Is More Always Better?
Not necessarily. The clinical trials showed a dose-response relationship — higher doses produced more weight loss on average. But individual responses vary significantly. Some patients lose 20%+ of body weight at 1mg. Others reach 2.4mg and plateau at 8%. The “right” dose is the one that produces good results with acceptable tolerability — which differs by individual. Regular check-ins with your prescriber to assess dose appropriateness are important.
Frequently Asked Questions
Q: What is the starting dose of semaglutide for weight loss?
A: The starting dose for weight loss is 0.25mg per week for the first 4 weeks. This is a sub-therapeutic dose used purely to allow the body to adapt and minimise gastrointestinal side effects. It is then increased to 0.5mg, and subsequently escalated every 4 weeks up to the target dose of 2.4mg/week (Wegovy) or the maximum tolerated dose.
Q: How long does semaglutide dose escalation take?
A: The standard Wegovy escalation schedule takes 16 weeks to reach the full 2.4mg maintenance dose: 0.25mg (weeks 1–4), 0.5mg (weeks 5–8), 1mg (weeks 9–12), 1.7mg (weeks 13–16), then 2.4mg maintenance. Compounded semaglutide providers often use similar schedules, sometimes with more gradual escalation options for patients with significant GI sensitivity.
Q: What if I can’t tolerate a dose increase?
A: If side effects are intolerable at a new dose, it is safe and common to stay at the previous dose for an additional 4 weeks before attempting re-escalation. There is no medical requirement to rush to the maximum dose — staying at a lower dose where you feel well is entirely reasonable. Some patients find their optimal balance at 1mg or 1.7mg rather than 2.4mg. Discuss any dose concerns with your prescribing physician.
📖 Further Reading
Start Semaglutide — Physician Supervised Dose Escalation
Compounded semaglutide from $149/month. No insurance required.
Sponsored | Affiliate link
Affiliate disclosure: This article contains affiliate links. See our Affiliate Disclosure.
Sources & References
- U.S. Food and Drug Administration (FDA) – Drug Approvals and Databases
- National Institutes of Health (NIH) – PubMed Medical Literature
- American Diabetes Association – Medication & Therapies
- Novo Nordisk – Clinical Research Data
- Eli Lilly – Medical Information
This content is regularly reviewed and updated to reflect the latest medical research and FDA guidance.